Expert contributions are critical to health technology assessment (HTA), particularly in rare diseas...
Read moreSpain has published Royal Decree 415/2026[1], setting out a new national framework for health techno...
Read moreEarly HTA scientific advice reduces price and reimbursement risk by informing ev...
Read moreWhile missing an EU Joint Scientific Consultation (JSC) is suboptimal, the greater strategic concern...
Read moreFrom 1 April 2026, AIFA’s updated HTA guidelines will come into effect, making ...
Read moreThe year 2026 marks a significant milestone for the European Union’s (EU) Health Tec...
Read moreThe HTA Coordination Group (HTACG) has now confirmed the 2026 request periods for joint scientific c...
Read moreISPOR Europe 2025 brought together global HTA bodies, payers, industry leaders and patient organisat...
Read more2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...
Read moreClinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...
Read more